16-57248574-C-CAAGTA
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_012106.4(ARL2BP):c.139_143dupAAGTA(p.Tyr48fs) variant causes a frameshift, stop gained change. The variant allele was found at a frequency of 0.00000413 in 1,452,778 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000041 ( 0 hom. )
Consequence
ARL2BP
NM_012106.4 frameshift, stop_gained
NM_012106.4 frameshift, stop_gained
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.78
Genes affected
ARL2BP (HGNC:17146): (ADP ribosylation factor like GTPase 2 binding protein) ADP-ribosylation factor (ARF)-like proteins (ARLs) comprise a functionally distinct group of the ARF family of RAS-related GTPases. The protein encoded by this gene binds to ARL2.GTP with high affinity but does not interact with ARL2.GDP, activated ARF, or RHO proteins. The lack of detectable membrane association of this protein or ARL2 upon activation of ARL2 is suggestive of actions distinct from those of the ARFs. This protein is considered to be the first ARL2-specific effector identified, due to its interaction with ARL2.GTP but lack of ARL2 GTPase-activating protein activity. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-57248574-C-CAAGTA is Pathogenic according to our data. Variant chr16-57248574-C-CAAGTA is described in ClinVar as [Pathogenic]. Clinvar id is 1373439.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL2BP | NM_012106.4 | c.139_143dupAAGTA | p.Tyr48fs | frameshift_variant, stop_gained | 3/6 | ENST00000219204.8 | NP_036238.1 | |
ARL2BP | XM_047433883.1 | c.43_47dupAAGTA | p.Tyr16fs | frameshift_variant, stop_gained | 3/6 | XP_047289839.1 | ||
LOC124903697 | XR_007065082.1 | n.1482_1486dupTACTT | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL2BP | ENST00000219204.8 | c.139_143dupAAGTA | p.Tyr48fs | frameshift_variant, stop_gained | 3/6 | 1 | NM_012106.4 | ENSP00000219204.3 | ||
ARL2BP | ENST00000563234.1 | c.130_134dupAAGTA | p.Tyr45fs | frameshift_variant, stop_gained | 3/6 | 2 | ENSP00000454237.1 | |||
ARL2BP | ENST00000562023.5 | c.101-1205_101-1201dupAAGTA | intron_variant | 3 | ENSP00000457465.1 | |||||
PLLP | ENST00000564376.1 | n.368_372dupTACTT | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000413 AC: 6AN: 1452778Hom.: 0 Cov.: 29 AF XY: 0.00000277 AC XY: 2AN XY: 722392
GnomAD4 exome
AF:
AC:
6
AN:
1452778
Hom.:
Cov.:
29
AF XY:
AC XY:
2
AN XY:
722392
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 17, 2021 | This sequence change creates a premature translational stop signal (p.Tyr48*) in the ARL2BP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ARL2BP are known to be pathogenic (PMID: 23849777, 27790702, 29718757, 30210231). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with ARL2BP-related conditions. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at